Singapore markets closed

ENDRA Life Sciences Inc. (NDRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.0971-0.0059 (-5.73%)
At close: 04:00PM EDT
0.0975 +0.00 (+0.41%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.82M
Enterprise value 6.01M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.85
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.32

Trading information

Stock price history

Beta (5Y monthly) 1.06
52-week change 3-93.45%
S&P500 52-week change 322.55%
52-week high 32.7900
52-week low 30.0690
50-day moving average 30.2212
200-day moving average 30.8710

Share statistics

Avg vol (3-month) 318.59M
Avg vol (10-day) 343.88M
Shares outstanding 570.27M
Implied shares outstanding 670.27M
Float 810.98M
% held by insiders 13.91%
% held by institutions 10.38%
Shares short (14 Jun 2024) 41.31M
Short ratio (14 Jun 2024) 40.04
Short % of float (14 Jun 2024) 41.87%
Short % of shares outstanding (14 Jun 2024) 41.86%
Shares short (prior month 15 May 2024) 4104.68k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 309 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-110.56%
Return on equity (ttm)-241.38%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -10.26M
Net income avi to common (ttm)-9.89M
Diluted EPS (ttm)-0.9100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.13M
Total cash per share (mrq)0.1
Total debt (mrq)415.02k
Total debt/equity (mrq)11.22%
Current ratio (mrq)1.04
Book value per share (mrq)0.34

Cash flow statement

Operating cash flow (ttm)-9.19M
Levered free cash flow (ttm)-2.76M